AbbVie Inc. (AbbVie) is a global research-based pharmaceuticals company. The Companyís products are used to treat chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohnís disease; human immunodeficiency virus (HIV); endometriosis; thyroid disease; Parkinsonís disease, and complications associated with chronic kidney disease and cystic fibrosis, among other health conditions, such as low testosterone. AbbVie's portfolio of products includes HUMIRA, Synthroid, AndroGel, Creon, Kaletra, Norvir, Lupron, Niaspan, TriCor, TRILIPIX, Synagis, Duodopa, Duopa, Zemplar and Sevoflurane AbbVie also has a pipeline of new medicines, including more than 20 compounds or indications in Phase II or Phase III development across medical specialties as immunology, virology/liver disease, oncology, renal disease, neurological diseases and womenís health. It markets medicines in approximately 170 countries.

Official website: www.abbvie.com